Current Trials

Some examples of our current Non- Commercial studies:-

 

Nihrscreenshot

 

Gladwebsiteimage

Genetic Links to Anxiety and Depression | GLAD Study

The Genetic Links to Anxiety and Depression (GLAD) Study is a project set up to support studies exploring risk factors for depression and/or anxiety. A deeper understanding of anxiety and depression, means we will be better equipped to help those who are experiencing them. In the UK, 1 in 3 people will experience symptoms of anxiety or depression during their lifetime, and treatment is only effective in about half of people, with symptoms often having devastating impacts on people’s quality of life. Together with your help, we want to change this. Help make a difference by signing up to GLAD today.

 Coatlogo

The COAT Study | Southampton Clinical Trials Unit | University of Southampton

Short 5-day course compared to longer 7-day course of oral flucloxacillin antibiotic for cellulitis in the leg

 

Studylogo

Home > MORE-KARE (exeter.ac.uk)

A Multi-centre investigation Of incREasing alcohol abstinence with Ketamine-Assisted psychological therapy in seveRE alcohol use disorder.

 

Impactlogo

The IMPACT-1 Study for PTSD (impact1study.com)

A clinical trial exploring the effect of an investigational, psychoactive oral medication for PTSD symptoms.

 

Our current Commercial Studies:-

Screenshot20250207111936

About the TRAILRUNNER-ALZ 3 Study

The TRAILRUNNER-ALZ 3 Study is evaluating an investigational medicine to see if it can help treat people with early Alzheimer’s disease.
Learn more about the TRAILRUNNER-ALZ 3 Study here. Brochure for Trailrunner ALZ 3 Stud

About the TRAILRUNNER-ALZ 3 Study

The TRAILRUNNER-ALZ 3 Study will see if an investigational medicine can help treat people with early Alzheimer’s disease.

You may be able to take part in this study if you:

  • Are aged 65 to 80 years old
  • Have no to mild issues with your memory
  • Are willing to obtain a blood test as part of the study that checks whether you have an abnormal protein association with Alzheimer’s disease
  • Have a reliable study partner*

 

*A study partner is a person who knows you well and would notice any changes in your memory, mood, or behavior. This could be your spouse, partner, friend, family memory, or someone whose job it is to help you. Your study partner would also need to consent to participate in the research study.

 

If you are interested in participating, the study doctor and staff will review additional eligibility criteria with you.

 

Study Overview

If you qualify to take part in the TRAILRUNNER-ALZ 3 Study, you will be randomly (that is by chance) assigned to either the investigational medicine group or the placebo group. For every 2 study participants, 1 will get investigational medicine and 1 will get placebo.

You will get an injection under the skin using a prefilled syringe. The first 5 doses will be at the clinic. The study team will give you these injections and show you how to do this. You or your study partner can give you the remaining injections at a convenient location, like at home, or you can go to the clinic. If your study partner is helping you, the study team will also show them how to give the injections.

This study will last about 5 years. It has 5 parts, including an optional extension to the study treatment period for eligible participants. After the observation period, if the investigational medicine is safe and effective, participants who received placebo may take part in the extension period and get investigational medicine. The study team will explain this to you in more detail.

During the study you will attend visits with doctors and researchers in-person at a clinic.

Your study partner should come to study visits with you. If they cannot come to a visit, they should be available by phone for any questions or follow-up. They must be able to tell the research team about any changes in your memory and thinking.